Collection Mémoires et thèses électroniques
AccueilÀ proposNous joindre

Bibliographie

1.Brochu J. Prise en charge du TCC: Suivons-nous les lignes directrices? Conférence: Traumatologie: Défis! 2002. Château Frontenac: Hôpital de l'Enfant-Jésus du CHA.

2.Ghigo E, Masel B, Aimaretti G et al. Consensus guidelines on screening for hypopituitarism following traumatic brain injury. Brain Inj, 2005. 19(9):711-24.

3.MSSS, Registre des traumatismes du québec. 2003, MSSS.

4.Fink MP, Abraham, E., Vincent, JL., Cochrane P.M., Textbook of critical care. Fifth ed. 2005, Philadelphia: Elsevier Saunders. pp. 1492-504.

5.Kaufman D, Mancebo, J., Corticosteroids in septic shock. 2006, UpToDate Online 14.3.

6.Selye H. A syndrome produced by diverse nocuous agents. 1936. J Neuropsychiatry Clin Neurosci, 1998. 10(2):230-1.

7.Cooper MS, Stewart PM. Corticosteroid insufficiency in acutely ill patients. N Engl J Med, 2003. 348(8):727-34.

8.Marik PE, Zaloga GP. Adrenal insufficiency in the critically ill: A new look at an old problem. Chest, 2002. 122(5):1784-96.

9.Streeten DH. What test for hypothalamic-pituitary-adrenocortical insufficiency? Lancet, 1999. 354(9174):179-80.

10.Clark PM, Neylon I, Raggatt PR et al. Defining the normal cortisol response to the short synacthen test: Implications for the investigation of hypothalamic-pituitary disorders. Clin Endocrinol (Oxf), 1998. 49(3):287-92.

11.Annane D, Sebille V, Troche G et al. A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA, 2000. 283(8):1038-45.

12.Annane D, Sebille V, Charpentier C et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA, 2002. 288(7):862-71.

13.Loisa P, Uusaro A, Ruokonen E. A single adrenocorticotropic hormone stimulation test does not reveal adrenal insufficiency in septic shock. Anesth Analg, 2005. 101(6):1792-8.

14.Bouachour G, Roy PM, Guiraud MP. The repetitive short corticotropin stimulation test in patients with septic shock. Ann Intern Med, 1995. 123(12):962-3.

15.Richards ML, Caplan RH, Wickus GG et al. The rapid low-dose (1 microgram) cosyntropin test in the immediate postoperative period: Results in elderly subjects after major abdominal surgery. Surgery, 1999. 125(4):431-40.

16.Broide J, Soferman R, Kivity S et al. Low-dose adrenocorticotropin test reveals impaired adrenal function in patients taking inhaled corticosteroids. J Clin Endocrinol Metab, 1995. 80(4):1243-6.

17.Mayenknecht J, Diederich S, Bahr V et al. Comparison of low and high dose corticotropin stimulation tests in patients with pituitary disease. J Clin Endocrinol Metab, 1998. 83(5):1558-62.

18.Abdu TA, Elhadd TA, Neary R, Clayton RN. Comparison of the low dose short synacthen test (1 microg), the conventional dose short synacthen test (250 microg), and the insulin tolerance test for assessment of the hypothalamo-pituitary-adrenal axis in patients with pituitary disease. J Clin Endocrinol Metab, 1999. 84(3):838-43.

19.Streeten DH, Anderson GH, Jr., Bonaventura MM. The potential for serious consequences from misinterpreting normal responses to the rapid adrenocorticotropin test. J Clin Endocrinol Metab, 1996. 81(1):285-90.

20.Marik PE, Zaloga GP. Adrenal insufficiency during septic shock. Crit Care Med, 2003. 31(1):141-5.

21.Yaegashi M, Boujoukos AJ. The low-dose acth test in the icu: Not ready for prime time. Crit Care, 2006. 10(4):313.

22.Hamrahian AH, Oseni, T.S., Arafah, B.M. Measurements of serum free cortisol in critically ill patients. N Engl J Med, 2004. 350(16):1629-38.

23.Gabay CK, I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med, 1999. 340(6):448-54.

24.Ho JT, Al-Musalhi H, Chapman MJ et al. Septic shock and sepsis: A comparison of total and free plasma cortisol levels. J Clin Endocrinol Metab, 2006. 91(1):105-14.

25.den Brinker M. Adrenal insufficiency in meningococcal sepsis: Bioavailable cortisol levels and impact of interleukin-6 levels and intubation with etomidate on adrenal function and mortality. Journal of Clinical Endocrinology & Metabolism, 2005. 90(9):5110-7.

26.Annane D, Briegel, J., Keh, D., Moreno, R., Singer, M., Sprung, C.L. Clinical equipoise remains for issues of adrenocorticotropic hormone administration, cortisol testing, and therapeutic use of hydrocortisone. Crit Care Med, 2003. 31(8):2250-3.

27.LaRosa S. Use of corticosteroids in the sepsis syndrome: What do we know now? Cleveland Clinic Journal of Medicine, 2005. 72(12):1121-7.

28.Li J, Murphy-Lavoie H, Bugas C et al. Complications of emergency intubation with and without paralysis. Am J Emerg Med, 1999. 17(2):141-3.

29.Dufour DG, Larose DL, Clement SC. Rapid sequence intubation in the emergency department. J Emerg Med, 1995. 13(5):705-10.

30.Sakles JC, Laurin EG, Rantapaa AA, Panacek EA. Airway management in the emergency department: A one-year study of 610 tracheal intubations. Ann Emerg Med, 1998. 31(3):325-32.

31.Bergen JM, Smith DC. A review of etomidate for rapid sequence intubation in the emergency department. J Emerg Med, 1997. 15(2):221-30.

32.Walls R, Manual of emergency airway management. Companion manual to the national emergency airway management course, ed. L.R. Walls RM, Murphy MF, Schneider RE. 2000, Philadelphia: Lippincott Williams & Wilkins. 240.

33.Marx J, Rosen's emergency medicine: Concepts and clinical practice. 5th edition ed. 2002, St. Louis: Mosby.

34.Giese JL, Stanley TH. Etomidate: A new intravenous anesthetic induction agent. Pharmacotherapy, 1983. 3(5):251-8.

35.Wadbrook PS. Advances in airway pharmacology. Emerging trends and evolving controversy. Emerg Med Clin North Am, 2000. 18(4):767-88.

36.Yeung J, Zed, PJ. A review of etomidate for rapid sequence intubation in the emergency department. CJEM, 2002. 4(3).

37.AANS, Management and prognosis of severe traumatic brain injury, in American association of neurological surgeons, joint section on neurotrauma and critical care. 2000, Brain Trauma Foundation. p. 116.

38.Zed PJ, Abu-Laban RB, Harrison DW. Intubating conditions and hemodynamic effects of etomidate for rapid sequence intubation in the emergency department: An observational cohort study. Acad Emerg Med, 2006. 13(4):378-83.

39.Ledingham IM, Watt I. Influence of sedation on mortality in critically ill multiple trauma patients. Lancet, 1983. 1(8336):1270.

40.Allolio B, Dorr H, Stuttmann R et al. Effect of a single bolus of etomidate upon eight major corticosteroid hormones and plasma acth. Clin Endocrinol (Oxf), 1985. 22(3):281-6.

41.Wagner RL, White PF, Kan PB et al. Inhibition of adrenal steroidogenesis by the anesthetic etomidate. N Engl J Med, 1984. 310(22):1415-21.

42.Wagner RL, White PF. Etomidate inhibits adrenocortical function in surgical patients. Anesthesiology, 1984. 61(6):647-51.

43.Fellows IW, Bastow MD, Byrne AJ, Allison SP. Adrenocortical suppression in multiply injured patients: A complication of etomidate treatment. Br Med J (Clin Res Ed), 1983. 287(6408):1835-7.

44.Fellows IW, Byrne AJ, Allison SP. Adrenocortical suppression with etomidate. Lancet, 1983. 2(8340):54-5.

45.Fellows IW, Yeoman PM, Selby C, Byrne AJ. The effect of anaesthetic induction with etomidate on the endocrine response to surgical trauma. Eur J Anaesthesiol, 1985. 2(3):285-90.

46.Oglesby AJ. Should etomidate be the induction agent of choice for rapid sequence intubation in the emergency department? Emerg Med J, 2004. 21(6):655-9.

47.Burton JH. Etomidate. Acad Emerg Med, 1995. 2(1):72-4.

48.Sokolove PE, Price DD, Okada P. The safety of etomidate for emergency rapid sequence intubation of pediatric patients. Pediatr Emerg Care, 2000. 16(1):18-21.

49.Willman E, Litchfield, A., Andolfatto, G. Etomidate and rapid sequence intubation. CJEM, 2005. 7(1):4.

50.Sagarin MJ, Barton ED, Chng YM, Walls RM. Airway management by us and canadian emergency medicine residents: A multicenter analysis of more than 6,000 endotracheal intubation attempts. Ann Emerg Med, 2005. 46(4):328-36.

51.Sivilotti M. You need tube, me give one amp of etomidate and sux. CJEM, 2006. 8(5):351-3.

52.Sivilotti ML, Filbin MR, Murray HE et al. Does the sedative agent facilitate emergency rapid sequence intubation? Acad Emerg Med, 2003. 10(6):612-20.

53.de Jong FH, Mallios C, Jansen C et al. Etomidate suppresses adrenocortical function by inhibition of 11 beta-hydroxylation. J Clin Endocrinol Metab, 1984. 59(6):1143-7.

54.Fragen RJ, Shanks CA, Molteni A, Avram MJ. Effects of etomidate on hormonal responses to surgical stress. Anesthesiology, 1984. 61(6):652-6.

55.Absalom A, Pledger D, Kong A. Adrenocortical function in critically ill patients 24h after a single dose of etomidate. Anaesthesia, 1999. 54(9):861-7.

56.Schenarts CL, Burton JH, Riker RR. Adrenocortical dysfunction following etomidate induction in emergency department patients. Acad Emerg Med, 2001. 8(1):1-7.

57.Diago MC, Amado JA, Otero M, Lopez-Cordovilla JJ. Anti-adrenal action of a subanaesthetic dose of etomidate. Anaesthesia, 1988. 43(8):644-5.

58.Nieman LK, Inhibitors of glucocorticoid biosynthesis or action. 2006, UpToDate online 14.2.

59.Dorr HG, Kuhnle U, Holthausen H et al. Etomidate: A selective adrenocortical 11 beta-hydroxylase inhibitor. Klin Wochenschr, 1984. 62(21):1011-3.

60.Duthie DJ, Fraser R, Nimmo WS. Effect of induction of anaesthesia with etomidate on corticosteroid synthesis in man. Br J Anaesth, 1985. 57(2):156-9.

61.Fraser R, Watt I, Gray CE et al. The effect of etomidate on adrenocortical function in dogs before and during hemorrhagic shock. Endocrinology, 1984. 115(6):2266-70.

62.Kenyon CJ, Young J, Gray CE, Fraser R. Inhibition by etomidate of steroidogenesis in isolated bovine adrenal cells. J Clin Endocrinol Metab, 1984. 58(5):947-9.

63.Lamberts SW, Bons EG, Bruining HA, de Jong FH. Differential effects of the imidazole derivatives etomidate, ketoconazole and miconazole and of metyrapone on the secretion of cortisol and its precursors by human adrenocortical cells. J Pharmacol Exp Ther, 1987. 240(1):259-64.

64.De Coster R, Beerens D, Haelterman C, Wouters L. Effects of etomidate on cortisol biosynthesis in isolated guinea-pig adrenal cells: Comparison with metyrapone. J Endocrinol Invest, 1985. 8(3):199-202.

65.Varga I, Racz K, Kiss R et al. Direct inhibitory effect of etomidate on corticosteroid secretion in human pathologic adrenocortical cells. Steroids, 1993. 58(2):64-8.

66.Wada A, Ohnishi T, Nonaka Y, Okamoto M. Inhibition of bovine adrenocortical mitochondrial cytochrome p-450(11)beta-mediated reactions by imidazole derivatives and mineralocorticoid analogs. J Steroid Biochem, 1988. 31(5):803-8.

67.Boidin MP, Erdmann WE, Faithfull NS. The role of ascorbic acid in etomidate toxicity. Eur J Anaesthesiol, 1986. 3(5):417-22.

68.Boidin MP. Steroid response to acth and to ascorbinic acid during infusion of etomidate for general surgery. Acta Anaesthesiol Belg, 1985. 36(1):15-22.

69.Pirbudak L, Balat O, Cekmen M et al. Effect of ascorbic acid on surgical stress response in gynecologic surgery. Int J Clin Pract, 2004. 58(10):928-31.

70.Schraag S, Pawlik M, Mohl U et al. The role of ascorbic acid and xylitol in etomidate-induced adrenocortical suppression in humans. Eur J Anaesthesiol, 1996. 13(4):346-51.

71.Nathan N, Vandroux JC, Feiss P. [role of vitamin C on adrenocortical effects of etomidate]. Ann Fr Anesth Reanim, 1991. 10(4):329-32.

72.De Paepe P, Belpaire FM, Van Hoey G et al. Influence of hypovolemia on the pharmacokinetics and the electroencephalographic effect of etomidate in the rat. J Pharmacol Exp Ther, 1999. 290(3):1048-53.

73.Johnson KB, Egan TD, Layman J et al. The influence of hemorrhagic shock on etomidate: A pharmacokinetic and pharmacodynamic analysis. Anesth Analg, 2003. 96(5):1360-8, table of contents.

74.Allolio B, Stuttmann R, Leonhard U et al. Adrenocortical suppression by a single induction dose of etomidate. Klin Wochenschr, 1984. 62(21):1014-7.

75.Crozier TA, Beck D, Schlaeger M et al. Endocrinological changes following etomidate, midazolam, or methohexital for minor surgery. Anesthesiology, 1987. 66(5):628-35.

76.Zurick A, Sigurdsson H, Koehler L et al. Magnitude and time course of perioperative adrenal suppression with single dose etomidate in male adult cardiac surgical patients. Anesthesiology, 1986. 65(3A):A248.

77.Boidin MP. Serum levels of cortisol in man during etomidate, fentanyl and air anesthesia, compared with neuroleptanesthesia. Acta Anaesthesiol Belg, 1985. 36(2):79-87.

78.Boidin MP. Modification of corticosteroid synthesis by etomidate/fentanyl and air anesthesia. Acta Anaesthesiol Belg, 1986. 37(3):213-8.

79.Stuttmann R, Allolio B, Becker A et al. [etomidate versus etomidate and hydrocortisone for anesthesia induction in abdominal surgical interventions]. Anaesthesist, 1988. 37(9):576-82.

80.Crozier TA, Flamm C, Speer CP et al. Effects of etomidate on the adrenocortical and metabolic adaptation of the neonate. Br J Anaesth, 1993. 70(1):47-53.

81.Malerba G, Romano-Girard F, Cravoisy A et al. Risk factors of relative adrenocortical deficiency in intensive care patients needing mechanical ventilation. Intensive Care Med, 2005. 31(3):388-92.

82.Bloomfield R, Noble DW. Etomidate and fatal outcome--even a single bolus dose may be detrimental for some patients. Br J Anaesth, 2006. 97(1):116-7.

83.Mohammad Z, Afessa B, Finkielman JD. The incidence of relative adrenal insufficiency in patients with septic shock after the administration of etomidate. Crit Care, 2006. 10(4):R105.

84.Annane D. ICU physicians should abandon the use of etomidate! Intensive Care Med, 2005. 31(3):325-6.

85.Bloomfield R, Noble DW. Exploring the role of etomidate in septic shock and acute respiratory distress syndrome. Crit Care Med, 2006. 34(6):1858; author reply -9.

86.Morris C, McAllister C. Etomidate for emergency anaesthesia; mad, bad and dangerous to know? Anaesthesia, 2005. 60(8):737-40.

87.Schulz-Stubner S. Sedation in traumatic brain injury: Avoid etomidate. Crit Care Med, 2005. 33(11):2723; author reply

88.Jackson WL, Jr. Should we use etomidate as an induction agent for endotracheal intubation in patients with septic shock?: A critical appraisal. Chest, 2005. 127(3):1031-8.

89.Zed P, VH. M, Slavik R, Abu-Laban R. Etomidate for rapid sequence intubation in the emergency department: Is adrenal suppression a concern? CJEM, 2006. 8(5):347-50.

90.Shirley PJ, McAuley DF. Etomidate--misused or misunderstood? Anaesthesia, 2006. 61(2):190; author reply 1.

91.Murray H, Marik PE. Etomidate for endotracheal intubation in sepsis: Acknowledging the good while accepting the bad. Chest, 2005. 127(3):707-9.

92.Hoen S, Asehnoune K, Brailly-Tabard S et al. Cortisol response to corticotropin stimulation in trauma patients: Influence of hemorrhagic shock. Anesthesiology, 2002. 97(4):807-13.

93.Price K, Allen U, Mandersloot G et al. Effect of a single dose of etomidate on adrenal function in patients with trauma [abstract]. Critical Care Medicine, 2005. 9((Suppl 1): P392):S163-S4.

94.Dimopoulou I, Tsagarakis S, Theodorakopoulou M et al. Endocrine abnormalities in critical care patients with moderate-to-severe head trauma: Incidence, pattern and predisposing factors. Intensive Care Med, 2004. 30(6):1051-7.

95.Agha A, Rogers B, Mylotte D et al. Neuroendocrine dysfunction in the acute phase of traumatic brain injury. Clin Endocrinol (Oxf), 2004. 60(5):584-91.

96.Dimopoulou I, Tsagarakis S, Kouyialis AT et al. Hypothalamic-pituitary-adrenal axis dysfunction in critically ill patients with traumatic brain injury: Incidence, pathophysiology, and relationship to vasopressor dependence and peripheral interleukin-6 levels. Crit Care Med, 2004. 32(2):404-8.

97.Bernard F, Outtrim J, Menon DK, Matta BF. Incidence of adrenal insufficiency after severe traumatic brain injury varies according to definition used: Clinical implications. Br J Anaesth, 2006. 96(1):72-6.

98.Tanriverdi F, Senyurek H, Unluhizarci K et al. High risk of hypopituitarism after traumatic brain injury: A prospective investigation of anterior pituitary function in the acute phase and 12 months after trauma. J Clin Endocrinol Metab, 2006. 91(6):2105-11.

99.Cohan P, Wang C, McArthur DL et al. Acute secondary adrenal insufficiency after traumatic brain injury: A prospective study. Crit Care Med, 2005. 33(10):2358-66.

100.Bevilacqua G, Fornaciari G. Clinico-pathological correlations in a case of traumatic pan-hypopituitarism. Acta Neuropathol (Berl), 1975. 31(2):171-77.

101.Bernard F, Matta BF. Adrenal insufficiency after brain injury. Intensive Care Med, 2006. 32(5):793.

102.Klingbeil GE, Cline P. Anterior hypopituitarism: A consequence of head injury. Arch Phys Med Rehabil, 1985. 66(1):44-6.

103.Delemer B, Touraine P. [traumatic brain injury and pituitary insufficiency]. Ann Endocrinol (Paris), 2006. 67(4):310-5.

104.Doghri T, Bouguerra R, Ezzaouia G et al. [post-traumatic anterior pituitary insufficiency. Apropos of 2 cases]. Ann Endocrinol (Paris), 1996. 57(2):117-21.

105.Edwards OM, Clark JD. Post-traumatic hypopituitarism. Six cases and a review of the literature. Medicine (Baltimore), 1986. 65(5):281-90.

106.Fernandez Castaner M, Ayma Sola J, Martinez de Osaba MJ, Vilardell E. [post-traumatic diabetes insipidus and hypopituitarism. Diagnostic evaluation of three cases (author's transl)]. Med Clin (Barc), 1982. 78(9):358-62.

107.Gnehm HE, Bernasconi S, Zachmann M. Posttraumatic anterior pituitary insufficiency in childhood. Helv Paediatr Acta, 1979. 34(6):529-35.

108.Lorenzo M, Peino R, Castro AI et al. Hypopituitarism and growth hormone deficiency in adult subjects after traumatic brain injury: Who and when to test. Pituitary, 2005. 8(3-4):233-7.

109.Paxson CL, Jr., Brown DR. Post-traumatic anterior hypopituitarism. Pediatrics, 1976. 57(6):893-6.

110.Samadani U, Reyes-Moreno I, Buchfelder M. Endocrine dysfunction following traumatic brain injury: Mechanisms, pathophysiology and clinical correlations. Acta Neurochir Suppl, 2005. 93:121-5.

111.Benvenga S. Brain injury and hypopituitarism: The historical background. Pituitary, 2005. 8(3-4):193-5.

112.Dimopoulou I, Tsagarakis S. Hypothalamic-pituitary dysfunction in critically ill patients with traumatic and nontraumatic brain injury. Intensive Care Med, 2005. 31(8):1020-8.

113.Acerini CL, Tasker RC, Bellone S et al. Hypopituitarism in childhood and adolescence following traumatic brain injury: The case for prospective endocrine investigation. Eur J Endocrinol, 2006. 155(5):663-9.

114.Agha A, Rogers B, Sherlock M et al. Anterior pituitary dysfunction in survivors of traumatic brain injury. J Clin Endocrinol Metab, 2004. 89(10):4929-36.

115.Agha A, Phillips J, O'Kelly P et al. The natural history of post-traumatic hypopituitarism: Implications for assessment and treatment. Am J Med, 2005. 118(12):1416.

116.Agha A, Thompson CJ. Anterior pituitary dysfunction following traumatic brain injury (tbi). Clin Endocrinol (Oxf), 2006. 64(5):481-8.

117.Aimaretti G, Ambrosio MR, Di Somma C et al. Traumatic brain injury and subarachnoid haemorrhage are conditions at high risk for hypopituitarism: Screening study at 3 months after the brain injury. Clin Endocrinol (Oxf), 2004. 61(3):320-6.

118.Aimaretti G, Ambrosio MR, Benvenga S et al. Hypopituitarism and growth hormone deficiency (GHD) after traumatic brain injury (TBI). Growth Horm IGF Res, 2004. 14 Suppl A:S114-7.

119.Aimaretti G, Ambrosio MR, Di Somma C et al. Hypopituitarism induced by traumatic brain injury in the transition phase. J Endocrinol Invest, 2005. 28(11):984-9.

120.Aimaretti G, Ghigo E. Traumatic brain injury and hypopituitarism. ScientificWorldJournal, 2005. 5:777-81.

121.Aimaretti G, Ambrosio MR, Di Somma C et al. Residual pituitary function after brain injury-induced hypopituitarism: A prospective 12-month study. J Clin Endocrinol Metab, 2005. 90(11):6085-92.

122.Baldelli R, Bellone S, Corneli G et al. Traumatic brain injury-induced hypopituitarism in adolescence. Pituitary, 2005. 8(3-4):255-7.

123.Bondanelli M, De Marinis L, Ambrosio MR et al. Occurrence of pituitary dysfunction following traumatic brain injury. J Neurotrauma, 2004. 21(6):685-96.

124.Cap J. [hormonal diseases after traumatic brain injury]. Vnitr Lek, 2006. 52(10):941-6.

125.Einaudi S, Matarazzo P, Peretta P et al. Hypothalamo-hypophysial dysfunction after traumatic brain injury in children and adolescents: A preliminary retrospective and prospective study. J Pediatr Endocrinol Metab, 2006. 19(5):691-703.

126.Giordano G, Aimaretti G, Ghigo E. Variations of pituitary function over time after brain injuries: The lesson from a prospective study. Pituitary, 2005. 8(3-4):227-31.

127.Herrmann BL, Rehder J, Kahlke S et al. Hypopituitarism following severe traumatic brain injury. Exp Clin Endocrinol Diabetes, 2006. 114(6):316-21.

128.Kelly DF, Gonzalo IT, Cohan P et al. Hypopituitarism following traumatic brain injury and aneurysmal subarachnoid hemorrhage: A preliminary report. J Neurosurg, 2000. 93(5):743-52.

129.Leal-Cerro A, Flores JM, Rincon M et al. Prevalence of hypopituitarism and growth hormone deficiency in adults long-term after severe traumatic brain injury. Clin Endocrinol (Oxf), 2005. 62(5):525-32.

130.Popovic V, Pekic S, Pavlovic D et al. Hypopituitarism as a consequence of traumatic brain injury (TBI) and its possible relation with cognitive disabilities and mental distress. J Endocrinol Invest, 2004. 27(11):1048-54.

131.Powner DJ, Boccalandro C, Alp MS, Vollmer DG. Endocrine failure after traumatic brain injury in adults. Neurocrit Care, 2006. 5(1):61-70.

132.Schneider HJ, Schneider M, Saller B et al. Prevalence of anterior pituitary insufficiency 3 and 12 months after traumatic brain injury. Eur J Endocrinol, 2006. 154(2):259-65.

133.Tsagarakis S, Tzanela M, Dimopoulou I. Diabetes insipidus, secondary hypoadrenalism and hypothyroidism after traumatic brain injury: Clinical implications. Pituitary, 2005. 8(3-4):251-4.

134.Agha A, Sherlock M, Thompson CJ. Post-traumatic hyponatraemia due to acute hypopituitarism. Qjm, 2005. 98(6):463-4.

135.Dimopoulou I, Tsagarakis S, Douka E et al. The low-dose corticotropin stimulation test in acute traumatic and non-traumatic brain injury: Incidence of hypo-responsiveness and relationship to outcome. Intensive Care Med, 2004. 30(6):1216-9.

136.Salgado DR, Verdeal JC, Rocco JR. Adrenal function testing in patients with septic shock. Crit Care, 2006. 10(5):R149.

137.Bernard F, Menon DK, Matta BF. Corticosteroids after traumatic brain injury: New evidence to support their use. Crit Care Med, 2006. 34(2):583; author reply 4.

138.Edouard A, Cortisol response to corticotropin stimulation in trauma patients: Influence of hemorrhagic shock [communication personnelle], P. Archambault, Editor. 2003: Paris.

139.Rushing GD, Britt RC, Collins JN et al. Adrenal insufficiency in hemorrhagic shock. Am Surg, 2006. 72(6):552-4.

140.Roberts I, Yates D, Sandercock P et al. Effect of intravenous corticosteroids on death within 14 days in 10008 adults with clinically significant head injury (mrc crash trial): Randomised placebo-controlled trial. Lancet, 2004. 364(9442):1321-8.

141.Edwards P, Arango M, Balica L et al. Final results of mrc crash, a randomised placebo-controlled trial of intravenous corticosteroid in adults with head injury-outcomes at 6 months. Lancet, 2005. 365(9475):1957-9.

142.Roberts I, Questions concerning the CRASH trial [communication personnelle], P. Archambault, Editor. 2006: London.

143.American college of chest physicians/society of critical care medicine consensus conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med, 1992. 20(6):864-74.

144.Hetherington H, Earlam RJ. Measurement of disability after multiple injuries: The functional independence measure. Clinical review. Eur J Surg, 1995. 161(8):549-55.

145.Keith RA, Granger CV, Hamilton BB, Sherwin FS. The functional independence measure: A new tool for rehabilitation. Adv Clin Rehabil, 1987. 1:6-18.

146.Marcin JP, Pollack MM. Triage scoring systems, severity of illness measures, and mortality prediction models in pediatric trauma. Crit Care Med, 2002. 30(11 Suppl):S457-67.

147.Lavoie A, Moore L, LeSage N et al. The injury severity score or the new injury severity score for predicting intensive care unit admission and hospital length of stay? Injury, 2005. 36(4):477-83.

148.Lavoie A, Moore L, LeSage N et al. The new injury severity score: A more accurate predictor of in-hospital mortality than the injury severity score. J Trauma, 2004. 56(6):1312-20.

149.Tien HC, Tremblay LN, Rizoli SB et al. Association between alcohol and mortality in patients with severe traumatic head injury. Arch Surg, 2006. 141(12):1185-91; discussion 92.

150.The brain trauma foundation. The american association of neurological surgeons. The joint section on neurotrauma and critical care. Glasgow coma scale score. J Neurotrauma, 2000. 17(6-7):563-71.

151.Bernard P, Biostatistique en épidémiologie [notes de cours]. 2002. chapitre 6 pp. 143-55.

152.Bond T.G. FCM, Applying the Rasch model : Fundamental measurement in the human sciences. 2001: Lawrence Erlbaum Associates, Inc Publishers.

153.Duncan L DN, Mosby's drug consult. 2002, St. Louis: Mosby Inc, An Elsevier Science Company.

154.Énoncé politique des trois conseils: Éthique de la recherche avec des êtres humains. 1998, Conseil de recherches médicales du Canada, Conseil de recherches en sciences naturelles et en génie du Canada, Conseil de recherches en sciences humaines du Canada.

155.MSSS, Plan d'action ministériel en éthique de la recherche et en intégrité scientifique. juin 1998, Ministère de la santé et des services sociaux, Direction des communications.

156.Sehdev RS, Symmons DA, Kindl K. Ketamine for rapid sequence induction in patients with head injury in the emergency department. Emerg Med Australas, 2006. 18(1):37-44.

157.Annane D, Sebille V, Bellissant E. Exploring the role of etomidate in septic shock and acute respiratory distress syndrome. Crit Care Med, 2006. 34(6):1858-9.

158.Campbell JP, Maxey VA, Watson WA. Hawthorne effect: Implications for prehospital research. Ann Emerg Med, 1995. 26(5):590-4.

159.Kokoska SM and Johnson LB. A comparison of statistical techniques for analysis of growth curves. Growth 1987; 51(2):261-9.

160.Watt I, Ledingham IM. Mortality amongst multiple trauma patients admitted to an intensive therapy unit. Anaesthesia, 1984. 39(10):973-81.

161.Annane D, Maxime V, Ibrahim F et al. Diagnosis of adrenal insufficiency in severe sepsis and septic shock. Am J Respir Crit Care Med, 2006.

162.Jones D, Hayes M, Webb S et al. Relative adrenal insufficiency in etomidate-naive patients with septic shock. Anaesth Intensive Care, 2006. 34(5):599-605.

163.Bloomfield R, Noble D. Etomidate and intensive care physicians. Intensive Care Med, 2005. 31(10):1453; author reply 4.

164.Benvenga S, Campenni A, Ruggeri RM, Trimarchi F. Clinical review 113: Hypopituitarism secondary to head trauma. J Clin Endocrinol Metab, 2000. 85(4):1353-61.

165.Angus DC, Linde-Zwirble WT, Lidicker J et al. Epidemiology of severe sepsis in the United-States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med, 2001. 29(7):1303-10.

166.Wichmann MW, Inthorn D, Andress HJ, Schildberg FW. Incidence and mortality of severe sepsis in surgical intensive care patients: The influence of patient gender on disease process and outcome. Intensive Care Med, 2000. 26(2):167-72.

167.Guzzo JL, Bochicchio GV, Napolitano LM et al. Prediction of outcomes in trauma: Anatomic or physiologic parameters? J Am Coll Surg, 2005. 201(6):891-7.

168.Kirkness CJ, Burr RL, Mitchell PH, Newell DW. Is there a sex difference in the course following traumatic brain injury? Biol Res Nurs, 2004. 5(4):299-310.

169.Kraus JF, Peek-Asa C, McArthur D. The independent effect of gender on outcomes following traumatic brain injury: A preliminary investigation. Neurosurg Focus, 2000. 8(1):e5.

170.Sampalis JS, Denis R, Fréchette P et al. Direct transport to tertiary trauma centers versus transfer from lower level facilities: Impact on mortality and morbidity among patients with major trauma. J Trauma, 1997. 43(2):288-95; discussion 95-6.

171.Pories SE, Gamelli RL, Vacek P et al. Intoxication and injury. J Trauma, 1992. 32(1):60-4.

172.Kraus JF, Morgenstern H, Fife D et al. Blood alcohol tests, prevalence of involvement, and outcomes following brain injury. Am J Public Health, 1989. 79(3):294-9.

173.Rappold JF, Coimbra R, Hoyt DB et al. Female gender does not protect blunt trauma patients from complications and mortality. J Trauma, 2002. 53(3):436-41; discussion 41.

174.Toschlog EA, MacElligot J, Sagraves SG et al. The relationship of injury severity score and Glasgow coma score to rehabilitative potential in patients suffering traumatic brain injury. Am Surg, 2003. 69(6):491-7; discussion 7-8.

175.Cowen TD, Meythaler JM, DeVivo MJ et al. Influence of early variables in traumatic brain injury on functional independence measure scores and rehabilitation length of stay and charges. Arch Phys Med Rehabil, 1995. 76(9):797-803.

176.Rana AI, Kenney PJ, Lockhart ME et al. Adrenal gland hematomas in trauma patients. Radiology, 2004. 230(3):669-75.

177.Sinelnikov AO, Abujudeh HH, Chan D, Novelline RA. CT manifestations of adrenal trauma: Experience with 73 cases. Emerg Radiol, 2007.

178.Pinto A, Scaglione M, Guidi G et al. Role of multidetector row computed tomography in the assessment of adrenal gland injuries. Eur J Radiol, 2006. 59(3):355-8.

179.Burks DW, Mirvis SE, Shanmuganathan K. Acute adrenal injury after blunt abdominal trauma: CT findings. AJR Am J Roentgenol, 1992. 158(3):503-7.

180.Schwarz M, Horev G, Freud E et al. Traumatic adrenal injury in children. Isr Med Assoc J, 2000. 2(2):132-4.

181.Sevitt S. Post-traumatic adrenal apoplexy. J Clin Pathol, 1955. 8(3):185-94.

182.Porter JM, Muscato K, Patrick JR. Adrenal hemorrhage: A comparison of traumatic and nontraumatic deaths. J Natl Med Assoc, 1995. 87(8):569-71.

183.Baccot S, Tiffet O, Bonnot P et al. [bilateral post-traumatic adrenal hemorrhage. Report of a case with acute adrenal insufficiency]. Ann Chir, 2000. 125(3):273-5.

184.Francque SM, Schwagten VM, Ysebaert DK et al. Bilateral adrenal haemorrhage and acute adrenal insufficiency in a blunt abdominal trauma: A case-report and literature review. Eur J Emerg Med, 2004. 11(3):164-7.

185.Rammelt S, Mucha D, Amlang M, Zwipp H. Bilateral adrenal hemorrhage in blunt abdominal trauma. J Trauma, 2000. 48(2):332-5.

186.Guichelaar MM, Leenen LP, Braams R. Transient adrenocortical insufficiency following traumatic bilateral adrenal hemorrhage. J Trauma, 2004. 56(5):1135-7.

187.Jaattela M, Ilvesmaki V, Voutilainen R et al. Tumor necrosis factor as a potent inhibitor of adrenocorticotropin-induced cortisol production and steroidogenic p450 enzyme gene expression in cultured human fetal adrenal cells. Endocrinology, 1991. 128(1):623-9.

188.Gonzalez H, Nardi O, Annane D. Relative adrenal failure in the ICU: An identifiable problem requiring treatment. Crit Care Clin, 2006. 22(1):105-18, vii.

189.Devlin EG, Clarke RS, Mirakhur RK, McNeill TA. Effect of four I.V. Induction agents on T-lymphocyte proliferations to phi in vitro. Br J Anaesth, 1994. 73(3):315-7.

190.Vermes I, Beishuizen A. The hypothalamic-pituitary-adrenal response to critical illness. Best Pract Res Clin Endocrinol Metab, 2001. 15(4):495-511.

191.Kay B. A dose-response relationship for etomidate, with some observations on cumulation. Br J Anaesth, 1976. 48(3):213-6.

© Patrick Archambault, 2007